Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
This is a Phase 1 study to evaluate the safety, tolerability, PK, and PD of ABF-101 in healthy participants and participants with age-related macular degeneration (AMD).
Part A and B [+11]
Part A and B [+25]
This is a Phase 1, open-label, dose-escalation study to assess the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of APX-343A monotherapy (Part A) and in combination with pembrolizumab (Part B) in subjects with advanced solid tumors.
Male or female subjects aged ≥19 years, inclusive, at the time of informed conse... [+12]
Received any prior immunotherapy. [+19]
This study is a multicenter, double-blinded, randomized, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, PK, and efficacy of Isuzinaxib compared with placebo in subjects with DKD.
Male/female subject aged ≥19 years inclusive at the time of informed consent. [+11]
History of type 1 diabetes mellitus or gestational diabetes. [+20]